<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autoinflammatory diseases encompass a group of <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> that are non-infectious, non-allergic, non-autoimmune and non-immunodeficient </plain></SENT>
<SENT sid="1" pm="."><plain>The term was initially coined for a small group of familial periodic <z:hpo ids='HP_0001945'>fever</z:hpo> syndromes of which familial Mediterranean <z:hpo ids='HP_0001945'>fever</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FMF</z:e>) is the most common and best known </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic and molecular analyses demonstrated for the majority of these diseases an impairment of inflammasomes to cause an increased activity of an interleukin-1-dependent <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Over the last years an increasing number of either rare hereditary syndromes or acquired common diseases could be summarized under the designation of autoinflammatory disease, thus creating an emerging new rubric of <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Many of them display cutaneous manifestations as both concomitant or more rarely main symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>To name some of them like <z:hpo ids='HP_0001055'>erysipelas</z:hpo>-like <z:hpo ids='HP_0010783'>erythema</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FMF</z:e>; <z:hpo ids='HP_0001025'>urticaria</z:hpo>-like <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor 1- or cryopyrin-associated <z:e sem="disease" ids="C0585274" disease_type="Disease or Syndrome" abbrv="">periodic syndromes</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">TRAPS</z:e>, CAPS), hyperimmunoglobulin D syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HIDS</z:e>) or <z:e sem="disease" ids="C0524988" disease_type="Disease or Syndrome" abbrv="">Schnitzler syndrome</z:e>; <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum and <z:hpo ids='HP_0001061'>acne</z:hpo> in PAPA syndrome; or <z:chebi fb="6" ids="22696">beh</z:chebi>Ã§etoid <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">aphthous ulcerations</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HIDS</z:e> and PFAPA syndrome </plain></SENT>
<SENT sid="6" pm="."><plain>Based on the new insights into pathogenesis one increasingly realizes the good response of these diseases to IL-1 antagonist therapies </plain></SENT>
</text></document>